F12 (IMAGE)
Caption
A molecular model of the F12 biotherapy shows the fold of its polypeptide backbone. Residual T cell epitopes are mapped onto the structure and colored from white (no epitopes) to dark red (dense overlapping epitopes). The muted red coloring indicates that T cell epitopes have been broadly silenced in the engineered F12 variant, and this reduced epitope content underlies the molecule's improved safety and efficacy profile.
Credit
Dartmouth Engineering
Usage Restrictions
None
License
Licensed content